Ever since the start of October when the Fed launched QE4 - or as
some still call it "Not QE" - in response to the Sept repo crisis,
figuring out the market has been pretty simple: if the Fed's balance
sheet goes up so does the S&P500, and vice versa.
The good news for traders is that for the past three months, the
Fed's balance sheet rose 11 of 12 weeks, and declined just 1 of 12, and
magically, the S&P did just that as well.
However, now that the year-end repo scare is history at least until
the April 15 tax date and certainly the next year end, it's time for the
Fed to start shrinking its balance sheet, mostly by allowing existing
term repo operations to expire without being rolled over. Conveniently,
the FOMC Minutes released moments ago provided the Fed's own big picture
take on when the massive liquidity injection since mid-September, which
expanded the Fed's balance sheet by $415BN in three and a half
months...
ｃ
... with the Fed pointing out its "expectations to gradually
transition away from active repo operations [in 2020] as Treasury bill
purchases supply a larger base of reserves" and specifically, "the calendar of repo operations starting in mid-January could reflect a gradual reduction in active repo operations."
None of this is new, and it has almost become conventional wisdom
that when the Fed starts draining liquidity, the market impact will be
the polar opposite of what happened when it was injecting liquidity:
i.e., stocks will drop.
So with the Fed highlighting mid-January as the period when the
liquidity injection goes into reverse, here is some more details on just
which dates will be critical: as Curvature's Scott Skyrm points out,
these will be the days when the Fed's term repos maturing over the next
few weeks, supposedly without being rolled into further term repos, or
as he puts it, "during January, it will be interesting to see how the market reacts to the term RP ops maturing:" FEDは１月半ばに流動性注入が反転することを強調している、ここに示すのはそのなかでも重要な日付だ：Curvature社の Scott Skyrmが指摘するものだ、今後数週でFEDのterm reposが満期を迎えるだろう、term repoの繰延は無いと仮定している、彼の言によると「１月中に、term repo満期に市場がどう反応するか興味深いところだ：」
$25 billion leaves the market on Monday,
月曜には＄２５Bが市場から引き去られる、
$28.8 billion on Tuesday,
火曜には＄２８．８Bが引き去られる、
$18 billion next Friday, etc.
金曜には＄１８Bが引きさられる、というぐあいだ。
Of course, perhaps "interesting" is not the
right word, because it is clear that if liquidity is drained without a
matching injection, the market reaction will be anything but favorable.
That said, the Fed still has more term Repo ops scheduled to correspond
with those term roll-off dates, with at least three more term RP ops of
up to $35 billion scheduled in January. Whether or not banks decide to
use these to roll existing maturing term repos will determine if the
liquidity cliff starts hitting next week, or 3-4 weeks later. Finally,
it will also depend on whether the Fed decides that it had overinjected
the market with liquidity, and if it announces even more scheduled term
repos in February and onward.
当然のことだが、たぶん「興味深い」という言葉は適当ではない、というのも当分の注入なしに流動性が引き去られるのは明らかで、市場の反応は決して好感を持つものではないだろう。ということは、FEDは１月にまださらに term repoの満期を控えている。商業銀行が既存term repoの満期を繰延するかどうかで来週または３，４週後に流動性の崖が始まるかどうかが決まる。最終的には、FEDが市場に流動性を過剰注入するかどうかにかかっているだろう、そして２月以降のterm repoのさらなる対応スケジュール開示に依存する。
For now, however, here is a visual calendar of when some of the key December term repos mature over the next few days:
多量のオピオイドを米国に送り込み、米国で深刻な麻薬中毒問題を引き起こしています。現代版「阿片戦争」です。あのトヨタ初の女性取締役もオピオイド中毒で逮捕解任されましたよね。 US Is Dependent On China For Almost 80% Of Its Medicine by Tyler Durden Fri, 05/31/2019 - 12:55 Experts are warning that the U.S. has become way too reliant on China for all our medicine , our pain killers, antibiotics, vitamins, aspirin and many cancer treatment medicine. 専門家はこう警告する、米国はすべての医薬品、痛み止め、抗生物質、ビタミン、アスピリン、各種抗がん剤で、中国依存度が高すぎる。 Fox Business reports that according to FDA estimates at least 80 percent of active ingredients found in all of America’s medicine come from abroad, primarily from China . And it’s not just the ingredients, China wants to become the world’s dominant generic drug maker. So far Chinese companies are making generic for everything from high blood pressure to chemotherapy drugs. 90 percent of America’s prescriptions a...
米国はよく理解してませんが、日本の場合では量的緩和で日銀が国債買い上げした資金は日銀当座預金にそのままです、市中には流れていません。でもNHKのニュース等では「ジャブジャブ」という表現をアナウンサーが使い、さらに丁寧に水道の蛇口からお金が吐き出される画像まで示してくれます。これって心理効果が大きいですよね。量的緩和とは何かを７時のニュースや新聞でこれ以上丁寧に解説するのはそう簡単ではありません。一般の人も株式をやっている人も「イメージ」で捉える以上はそう簡単にできません。多くの人は量的緩和とはなにか、を理解していないと私は想像しています。 ただし、国債を買い上げるので長期金利が低下し住宅ローン金利等が下がったのは確実な効果です。一方で長短金利差が少なくなると銀行のビジネスモデルが成り立たなくなりますが。 This Is The One Chart Every Trader Should Have "Taped To Their Screen" by Tyler Durden Sat, 01/19/2019 - 18:55 After a year of tapering, the Fed’s balance sheet finally captured the market’s attention during the last three months of 2018. 一年間のテーパリング後、FEDバランスシートがとうとう市場の注目をあびることになった、２０１８年の最後の３ヶ月だ。 By the start of the fourth quarter, the Fed had finished raising the caps on monthly roll-off of its balance sheet to the full $50bn per month (peaking at $30bn USTs, $20bn MBS...
後講釈なんですが、６月option(５月28日 expire）の$2400 Call Optionが out of the moneyになりました。６月optionは特にOpen Interest が大きい。きっかけはFED高官の発言のようですが、Option Writerにはまちかまえていたものでしょう。 ただ、これも今月末のexpireをすぎれば圧力は無くなると思います。
